Preclinical evaluation of F-18-PSMA PET in glioblastoma as a potential theranostic approach

Published: Apr 1, 2020
Abstract
Ziel/Aim The prostate specific membrane antigen (PSMA) is not only overexpressed in prostate cancer cells but also in tumor-associated neovasculature of non-prostatic malignancies. The goal of our research is to evaluate the potential of PET imaging using F-18-PSMA in a murine glioblastoma model and to evaluate its potential for a theranostic approach to glioblastoma...
Paper Details
Title
Preclinical evaluation of F-18-PSMA PET in glioblastoma as a potential theranostic approach
Published Date
Apr 1, 2020
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.